TECH · News · 20260806N

Market Demand Trends

BIO-TECHNE Corp · 2026-08-06 · Importance 22 · Surprise 32

The global research-use-only recombinant protein market is projected to grow from $1.11 billion in 2026 to $1.55 billion by 2031, representing a 7.0% CAGR. Demand is being driven by expanding drug discovery, preclinical research, and increased use of advanced cell-based models. North America is the largest market, while Asia Pacific is expected to be the fastest-growing region.

Key facts

• Bio-Techne is benefiting from subsiding temporary headwinds, including improving academic funding and strong large pharmaceutical customer demand. source
• Analysts hold a "Hold" consensus rating on Bio-Techne with an average price target of $68.08. source
• Conestoga Capital Advisors highlighted Bio-Techne Corporation (TECH) as a performance contributor in its Q2 2026 investor letter. source
• Bio-Techne's stock opened at $72.00, near its 52-week high. source